2012
DOI: 10.1007/s10456-012-9294-9
|View full text |Cite
|
Sign up to set email alerts
|

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture

Abstract: Increasing experimental evidence suggests that IGF-1 may modulate tumor angiogenesis via activation of the expression of VEGF in Ewing sarcomas and rhabdomyosarcomas. This study investigates the effects of the PEGylated Adnectins™ CT-322, a VEGFR2-inhibitor and AT580Peg40, an IGF-1R inhibitor, as monotherapy and in combination in a murine A673 xenograft tumor model. The combination of Adnectins CT-322 and AT580Peg40 revealed a 83% reduction in tumor growth, a nearly 5 times lower vessel density, less necrotic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
35
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 58 publications
(45 citation statements)
references
References 27 publications
6
35
0
1
Order By: Relevance
“…The latter is a well-characterized morphogenetic process which can be observed during growth and remodeling of pre-existing networks [8, 9]. A distinguishing anatomic feature of intussusceptive angiogenesis is the intussusceptive pillar.…”
Section: Introductionmentioning
confidence: 99%
“…The latter is a well-characterized morphogenetic process which can be observed during growth and remodeling of pre-existing networks [8, 9]. A distinguishing anatomic feature of intussusceptive angiogenesis is the intussusceptive pillar.…”
Section: Introductionmentioning
confidence: 99%
“…Adnectins are extracellular type III domain of human fibronectin derived scaffold proteins with a molecular weight of about 10 kDa [15]. The domain has a structure similar to antibody variable domains.…”
Section: Monobodies/adnectinmentioning
confidence: 99%
“…Treatment with AT580Peg40 inhibits IGF-mediated VEGF secretion. The combination inhibition of IGF and VEGF signaling with CT-322 and AT580Peg40 significantly inhibits primary tumor growth and angiogenesis [9].…”
Section: Pre-clinical Studiesmentioning
confidence: 99%